Debiopharm
Antoine Attinger is an experienced pharmaceutical professional with a robust background in translational pharmacology and immunology. Currently serving as Associate Director of Translational Pharmacology at Debiopharm since July 2013, Antoine has previously held positions such as Associate Principal Scientist and Senior Research Officer within the same company. Prior experience includes leading teams at Merck Serono focused on early pharmacokinetics and pharmacodynamics in Multiple Sclerosis, and managing immunology and assay development at Glenmark Pharmaceuticals. Antoine's earlier roles encompass senior research scientist responsibilities at Apoxis SA and a post-doctoral fellowship at the La Jolla Institute for Allergy and Immunology. Antoine began academic training with a PhD in Immunology from the University of Lausanne, completed in 2000.
This person is not in the org chart
This person is not in any teams
Debiopharm
2 followers
Debiopharm Group is a biopharmaceutical development specialist that in-licenses promising biologics and small molecule drug candidates. They develop their products for global registration and maximum commercial potential for out-licensing to pharmaceutical partners for sales and marketing.